Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Express Scripts
Colorcon
Baxter
Johnson and Johnson

Last Updated: May 24, 2022

PHOTREXA VISCOUS IN DEXTRAN 20% Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

When do Photrexa Viscous In Dextran 20% patents expire, and what generic alternatives are available?

Photrexa Viscous In Dextran 20% is a drug marketed by Glaukos and is included in one NDA.

The generic ingredient in PHOTREXA VISCOUS IN DEXTRAN 20% is riboflavin 5'-phosphate sodium. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the riboflavin 5'-phosphate sodium profile page.

Drug patent expirations by year for PHOTREXA VISCOUS IN DEXTRAN 20%
Anatomical Therapeutic Chemical (ATC) Classes for PHOTREXA VISCOUS IN DEXTRAN 20%

US Patents and Regulatory Information for PHOTREXA VISCOUS IN DEXTRAN 20%

PHOTREXA VISCOUS IN DEXTRAN 20% is protected by zero US patents and two FDA Regulatory Exclusivities.

FDA Regulatory Exclusivity protecting PHOTREXA VISCOUS IN DEXTRAN 20%

TREATMENT OF CORNEAL ECTASIA FOLLOWING REFRACTIVE SURGERY
Exclusivity Expiration: See Plans and Pricing

TREATMENT OF PROGRESSIVE KERATOCONUS
Exclusivity Expiration: See Plans and Pricing

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaukos PHOTREXA VISCOUS IN DEXTRAN 20% riboflavin 5'-phosphate sodium SOLUTION/DROPS;OPHTHALMIC 203324-002 Apr 15, 2016 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Glaukos PHOTREXA VISCOUS IN DEXTRAN 20% riboflavin 5'-phosphate sodium SOLUTION/DROPS;OPHTHALMIC 203324-002 Apr 15, 2016 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Express Scripts
McKinsey
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.